European Society for Blood and Marrow Transplantation 4th European CAR T-cell Meeting 2022
Format: 37 videos + 1 pdf, size: 19.3 GB
Course Audience: hematologist, oncologist
Overview:
The European Hematology Association (EHA) and the EBMT are excited to announce the 4th edition of the jointly organized European CAR T-cell Meeting. This meeting will be fully virtual.
Dates: February 10-12, 2022 Chairs: Michael Hudecek & Ibrahim Yakoub-Agha Format: Virtual
The meeting will cover a broad range of topics including deep science and translational, clinical and commercial development in the field of CAR T. The programme will bring you all the latest in CAR T and will even bring in the first ever reported clinical data.
Join the meeting to be able to hear the latest developments and to have the chance to discuss this important topic with both experts and your peers.
Target Audience
The target audience is hematologists, oncologists, physicians, nurses, data managers, supply chain managers, patient organization representatives, patients, biothech representatives, industry representatives, pharmacists and manufacturers.
pdf-program (PDF Format)
BA01 – Best abstracts & Awards (Video MP4 Format)BA02 – Best abstracts flash talks (Video MP4 Format)BA03 – Best abstracts flash talks (Video MP4 Format)CLS – Closing remarks (Video MP4 Format)IT02 – Industry Theatre (Auditorium 1) The Future of CART by Novartis (Video MP4 Format)IT03 – Industry Theatre (Auditorium 1) Kite as innovators in CAR T-cell therapy manufacturing and delivery (Video MP4 Format)KN01 – Keynote Lecture 1 (Video MP4 Format)KN02 – Keynote Lecture 2 (Video MP4 Format)KN03 – Panel Chairs & Keynote Lecture 3 (Video MP4 Format)KN04 – Keynote Lecture 4 (Video MP4 Format)NG01 – Nurses Session I – Overview (Video MP4 Format)NG02 – Nurses Session II – Treatment Updates (Video MP4 Format)NG03 – Nurses Session III – Patient Experience (Video MP4 Format)NG04 – Nurses Session IV – Treatment outcome influencers (Video MP4 Format)OP01 – Opening (Video MP4 Format)OPN1 – Introduction & Welcome + NG00 – The Nice Experience (Video MP4 Format)PA01 – Things you need to know about CAR T-cell therapy talking about CAR-T cell therapy in lay (Video MP4 Format)PS01 – Session 1 – Clinical Indications (Video MP4 Format)PS02 – Session 2 – New Clinical Data and Trial Pipeline (Video MP4 Format)PS03 – Session 3 – Next-Gen CAR-T Therapy (Video MP4 Format)PS04 – Session 4 – CAR-T in Oncology (Video MP4 Format)PS05 – Session 5 – Interactive pros cons (Video MP4 Format)PS06 – Session 6 – New CAR-T Indications (Video MP4 Format)PS07 – Session 7 – CAR-T New Standard of Care in Lymphoma (Video MP4 Format)PS08 – Session 08 – Clinical management (Video MP4 Format)PS09 – Session 09 – CAR T Technology Forum (Video MP4 Format)PS10 – Session 10 – How to set-up and run a CAR-T unit (Video MP4 Format)PS11 – Session 11 – Biotech Forum (Video MP4 Format)PS12 – Session 12 – Trial management (Video MP4 Format)PT01 – Virtual Poster Tour 1 Pre-clinical Data (Video MP4 Format)PT02 – Virtual Poster Tour 2 Clinical data (Video MP4 Format)PT03 – Virtual Poster Tour 3 Pre-clinical Data (Video MP4 Format)PT04 – Virtual Poster Tour 4 Clinical Data (Video MP4 Format)SS01 – Satellite symposium by Janssen Transforming the landscape of multiple myeloma with CAR T-cell therapies (Video MP4 Format)SS02 – Satellite symposium by Bristol Myers Squibb CAR T cell therapy current status and new (Video MP4 Format)SS04 – Satellite Symposium by Gilead Kite on R R DLBCL highlights in CAR T from ASH 2021 (Video MP4 Format)YA01 – EBMT Trainee Committee & YoungEHA Ambassadors (Video MP4 Format)